Gloria Chan

1.4k total citations · 1 hit paper
24 papers, 829 citations indexed

About

Gloria Chan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Gloria Chan has authored 24 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Gloria Chan's work include Cancer Immunotherapy and Biomarkers (6 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Gloria Chan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Gloria Chan collaborates with scholars based in Singapore, United States and Taiwan. Gloria Chan's co-authors include Cheng Ean Chee, Sing-Fai Leung, Yuk Ming Dennis Lo, Rossa W. K. Chiu, Andrew C. van Hasselt, K.C. Allen Chan, Anthony T.�C. Chan, Brigette Ma, Suet Yi Leung and W.K. Lam and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Gloria Chan

23 papers receiving 814 citations

Hit Papers

Analysis of Plasma Epstein–Barr Virus DNA to Screen for N... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers

Gloria Chan
M. Frikha Tunisia
Marlinda Adham Indonesia
Renske Fles Netherlands
Jessica H. Maxwell United States
Matthew E. Witek United States
Gloria Chan
Citations per year, relative to Gloria Chan Gloria Chan (= 1×) peers L. Iglesias

Countries citing papers authored by Gloria Chan

Since Specialization
Citations

This map shows the geographic impact of Gloria Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria Chan more than expected).

Fields of papers citing papers by Gloria Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria Chan. The network helps show where Gloria Chan may publish in the future.

Co-authorship network of co-authors of Gloria Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria Chan. A scholar is included among the top collaborators of Gloria Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria Chan. Gloria Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pathak, Priyadarshini, Gloria Chan, Dustin A. Deming, & Cheng Ean Chee. (2024). State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation. American Society of Clinical Oncology Educational Book. 44(3). e438466–e438466. 17 indexed citations
3.
Ow, Samuel G.W., Gloria Chan, David S.P. Tan, et al.. (2024). Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world. ESMO Open. 9(6). 103482–103482. 4 indexed citations
4.
Choo, Joan, Bernadette Reyna Asuncion, Benjamin Kye Jyn Tan, et al.. (2023). Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer. Gastric Cancer. 26(3). 393–404. 12 indexed citations
5.
Lim, Joline S.J., Samuel G.W. Ow, Andrea L.A. Wong, et al.. (2023). Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines. European Journal of Cancer. 193. 113311–113311. 1 indexed citations
6.
Choo, Joan, Sun Young Rha, Haining Tan, et al.. (2022). 1255P da VINci: Safety and efficacy of the OTSGC-A24 vaccine and nivolumab in metastatic gastric cancer. Annals of Oncology. 33. S1121–S1121.
7.
Puhaindran, Mark E., et al.. (2022). Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore. Hereditary Cancer in Clinical Practice. 20(1). 23–23. 1 indexed citations
8.
Choo, Joan, Yi‐Hua Jan, Samuel G.W. Ow, et al.. (2022). Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors. Targeted Oncology. 17(3). 355–368. 1 indexed citations
9.
Lim, Joline S.J., Joan Choo, Samuel G.W. Ow, et al.. (2021). Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer. Breast Cancer Research and Treatment. 192(1). 131–142. 13 indexed citations
10.
Chia, Daryl Kai Ann, Raghav Sundar, Guowei Kim, et al.. (2021). Outcomes of a phase II study of intraperitoneal paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases.. Journal of Clinical Oncology. 39(3_suppl). 165–165. 6 indexed citations
11.
Zhao, Joseph J., Nesaretnam Barr Kumarakulasinghe, Matilda Lee, et al.. (2021). Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience. Oncology. 99(3). 192–202. 16 indexed citations
12.
Chan, Gloria & Cheng Ean Chee. (2020). Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer. Cancers. 12(12). 3535–3535. 12 indexed citations
13.
Chan, Gloria, Yiqing Huang, Yvonne Ang, et al.. (2019). P2.04-36 Immune Checkpoint Inhibition for Non-Small Cell Lung Cancer (NSCLC) in Patients with Pulmonary Tuberculosis or Hepatitis B. Journal of Thoracic Oncology. 14(10). S722–S722. 1 indexed citations
14.
Chan, Gloria & Cheng Ean Chee. (2019). Making sense of adjuvant chemotherapy in colorectal cancer. Journal of Gastrointestinal Oncology. 10(6). 1183–1192. 65 indexed citations
15.
Bandla, Aishwarya, Nesaretnam Barr Kumarakulasinghe, Yiqing Huang, et al.. (2019). Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy. Supportive Care in Cancer. 28(8). 3691–3699. 22 indexed citations
16.
Walsh, Robert J., et al.. (2019). The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 11. 3862485400–3862485400. 44 indexed citations
17.
Chan, Gloria, et al.. (2018). Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers. Oncotarget. 9(55). 30649–30660. 25 indexed citations
18.
Chan, K.C. Allen, John K. S. Woo, Ann D. King, et al.. (2017). Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer. New England Journal of Medicine. 377(6). 513–522. 501 indexed citations breakdown →
19.
Mah, Linda, Manish Kohli, & Gloria Chan. (2014). Ambient lead exposure is associated with greater risk of conversion to Alzheimer's disease and hippocampal atrophy in individuals with amnestic mild cognitive impairment. American Journal of Geriatric Psychiatry. 22(3). S117–S118. 1 indexed citations
20.
Chan, Gloria, et al.. (2000). Ageing and Fitness to Work. Occupational Medicine. 50(7). 483–491. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026